ARA-290 vs KPV: Full Comparison
A comparison of tissue-protective cytokine signaling via ARA-290 peptide acting on innate repair receptor pathways versus anti-inflammatory melanocortin pathway modulation through KPV peptide in immunoregulation and inflammatory response research.
Overview of Both Compounds
ARA-290 and KPV are peptides studied in laboratory research contexts involving immune-related signaling systems under investigation, particularly those associated with cellular communication, tissue-response signaling, and receptor-mediated pathway activity.
ARA-290 is a synthetic peptide derived from erythropoietin (EPO), studied in research models for its interaction with non-erythropoietic receptor-associated signaling pathways under investigation.
KPV is a naturally occurring tripeptide (Lys–Pro–Val) derived from alpha-melanocyte-stimulating hormone (α-MSH), studied in laboratory models for its interaction with melanocortin receptor–associated signaling pathways under investigation.
Key Differences
| Feature | ARA-290 | KPV |
|---|---|---|
| Origin | EPO-derived peptide fragment | α-MSH-derived tripeptide |
| Structure | 11-amino acid peptide | 3-amino-acid peptide |
| Primary Research Focus | System-level immune signaling pathways | Localized epithelial signaling pathways |
| Receptor Association | Non-erythropoietic receptor systems | Melanocortin receptor–associated systems |
| Research Systems | Neural, vascular, immune signaling models | Gastrointestinal, dermal, epithelial models |
| Scope of Activity | System-level signaling interactions | Localized tissue signaling interactions |
Mechanism Comparison
ARA-290 (Research Context)
ARA-290 is studied in models involving non-erythropoietic EPO receptor–associated signaling pathways under investigation.
- Immune-related signaling pathway in experimental models
- Neurovascular signaling system interactions under investigation
- Endothelial signaling pathway activity in controlled models
- Cellular stress-response–associated signaling networks
- System-level inflammatory signaling interactions
KPV (Research Context)
KPV is studied as an α-MSH–derived tripeptide involved in melanocortin receptor–associated signaling pathways under investigation.
- Epithelial signaling pathway in research models
- Mucosal and gastrointestinal signaling systems
- Dermal and barrier-related signaling pathway models
- NF-κB–associated signaling pathway interactions
- Localized cellular stress-response–associated signaling
Research Applications
- Neurovascular signaling system models
- Immune-related signaling pathway studies
- Endothelial signaling research systems
- Epithelial signaling pathway models
- Gastrointestinal and mucosal research
- Dermal barrier signaling studies
Comparison Based on Research Objectives
- System-level signaling models → ARA-290
- Local epithelial signaling models → KPV
- Neurovascular communication research → ARA-290
- Barrier tissue signaling research → KPV
Simple Summary
KPV → localized epithelial and barrier signaling model
Side-by-Side Summary
ARA-290 and KPV are studied in immune-related signaling research but operate at different biological levels. ARA-290 is associated with system-level signaling networks involving vascular and neural communication pathways, while KPV is associated with localized epithelial and mucosal signaling pathways.
Sourcing & Quality Considerations
- ≥98% purity confirmed via HPLC
- Mass spectrometry verification of identity
- Batch-level traceability and documentation
- Endotoxin testing for laboratory environments
- Stability validation under controlled storage conditions
- Sequence integrity confirmation